Alzheimer's Association® Company Profile

Background

Founded in 1980, the Alzheimer's Association is a leading voluntary health organization dedicated to Alzheimer's care, support, and research. Its mission is to eliminate Alzheimer's disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. With headquarters in Chicago, Illinois, and a public policy office in Washington, D.C., the Association operates numerous chapters across the United States, offering localized support and resources.

Key Strategic Focus

The Alzheimer's Association focuses on several strategic areas:

Care and Support: Providing comprehensive services, including a 24/7 Helpline staffed by master's-level clinicians, support groups, educational programs, and online resources to assist individuals living with Alzheimer's and their caregivers.

Research Advancement: As the largest nonprofit funder of Alzheimer's research, the Association is committed to accelerating global progress toward treatments, preventions, and a cure. It currently invests over $430 million in more than 1,150 active projects across 57 countries.

Public Policy and Advocacy: Advocating at federal and state levels to influence policy changes, secure increased research funding, and improve care and support services for those affected by Alzheimer's. Notable achievements include the reauthorization of the BOLD Public Health Legislation and the National Alzheimer's Project Act.

Diversity, Equity, and Inclusion: Engaging underrepresented and underserved communities to ensure equitable access to resources, education, and support services.

Financials and Funding

In the fiscal year ending June 30, 2023, the Alzheimer's Association reported total revenue of $442 million, with private donations accounting for $383 million and government support contributing $28 million. Total expenses were $471 million, resulting in a deficit of $29 million. The organization maintains net assets of $293 million. Approximately 79% of expenses are allocated to charitable services, reflecting a strong commitment to its mission.

Pipeline Development

While the Alzheimer's Association does not develop pharmaceutical products, it plays a pivotal role in funding and facilitating research initiatives. The Association currently invests over $430 million in more than 1,150 active projects across 57 countries, focusing on various aspects of Alzheimer's disease, including early detection, treatment development, and prevention strategies.

Technological Platform and Innovation

The Alzheimer's Association leverages various technological platforms to enhance its outreach and support services:

Digital Tools: Utilizing a tech stack that includes tools like Curalate, Microsoft Power BI, and WordPress, the Association demonstrates a commitment to innovation. These platforms support digital dementia care navigation tools, offering valuable resources to healthcare providers, caregivers, and individuals impacted by Alzheimer's.

Online Resources: Providing comprehensive online educational materials, support forums, and virtual events to reach a broader audience and facilitate community engagement.

Leadership Team

The Alzheimer's Association is led by a team of experienced professionals dedicated to advancing the organization's mission:

Joanne Pike, DrPH: President and Chief Executive Officer. Dr. Pike succeeded Harry Johns in January 2023, becoming the first woman to hold these positions in the organization's history.

Maria Carrillo, Ph.D.: Chief Science Officer. Dr. Carrillo oversees the Association's global research initiatives and scientific programs.

Robert Egge: Chief Public Policy Officer. Egge leads the Association's public policy and advocacy efforts at federal and state levels.

Donna McCullough: Chief Operating Officer. McCullough manages the Association's operations and strategic initiatives.

Leadership Changes

In January 2023, Joanne Pike succeeded Harry Johns as President and CEO of the Alzheimer's Association, marking a significant leadership transition. Dr. Pike's appointment reflects the organization's commitment to advancing its mission under experienced leadership.

Competitor Profile

Market Insights and Dynamics

The Alzheimer's care and research sector comprises various organizations dedicated to supporting individuals affected by Alzheimer's and advancing research toward treatment and prevention. The market is characterized by a collaborative approach among nonprofits, research institutions, and healthcare providers to address the multifaceted challenges posed by Alzheimer's disease.

Competitor Analysis

Key organizations in the Alzheimer's care and research landscape include:

Alzheimer's Foundation of America (AFA): Provides support services to individuals with Alzheimer's and their caregivers, including a national toll-free helpline and free memory screenings.

Alzheimer's Research UK: Focuses on funding research to understand, diagnose, treat, and prevent Alzheimer's disease. The organization has invested significantly in research initiatives and public awareness campaigns.

Alzheimer's Society (UK): Offers care and support services, funds research, and campaigns for policy changes to improve the lives of people affected by dementia. The society provides local activity groups, support programs, and educational resources.

Alzheimer's Drug Discovery Foundation (ADDF): Aims to accelerate the discovery of drugs to prevent, treat, and cure Alzheimer's disease by funding research in academia and the biotech industry.

Strategic Collaborations and Partnerships

The Alzheimer's Association collaborates with various organizations to strengthen its mission:

Alzheimer's Impact Movement (AIM): A separately incorporated advocacy affiliate that works to secure policies to overcome Alzheimer's and dementia, including increased investment in research and improved care and support.

Corporate Partnerships: Engages with corporations such as Marshalls, BJ's Restaurants, and Procter & Gamble to raise funds and awareness through campaigns and events. For instance, Marshalls customers have contributed nearly $20 million since 2013 to support the Association's mission.

Operational Insights

The Alzheimer's Association's strategic initiatives, robust financial health, and extensive network of chapters position it as a leader in the Alzheimer's care and research sector. Its comprehensive approach, encompassing care and support services, research funding, advocacy, and public education, differentiates it from competitors and enhances its impact on the community.

Strategic Opportunities and Future Directions

Looking ahead, the Alzheimer's Association aims to:

Expand Research Funding: Increase investment in innovative research projects to accelerate the discovery of treatments and a cure for Alzheimer's disease.

Enhance Care and Support Services: Broaden the reach and accessibility of support services, particularly in underserved communities, to ensure equitable access to resources.

Strengthen Advocacy Efforts: Continue to influence public policy to secure increased funding for research and improved care standards for individuals affected by Alzheimer's.

Leverage Technology: Utilize digital platforms to disseminate information, provide virtual support, and engage a broader audience in the fight against Alzheimer's disease.